Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer

  Free Subscription


10.08.2026

2 Abdom Radiol (NY)
1 Acta Cytol
1 Acta Med Port
1 Acta Obstet Gynecol Scand
1 Acta Oncol
2 AJOG Glob Rep
1 Am J Case Rep
1 Ann Ib Postgrad Med
2 BMJ Open
1 Cancer Cytopathol
1 Cancer Epidemiol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Rep (Hoboken)
1 Cell Rep Med
1 Clin Exp Vaccine Res
1 Clin J Oncol Nurs
1 Clin Med Insights Oncol
1 Clin Nucl Med
1 Clin Oncol (R Coll Radiol)
1 Comput Struct Biotechnol J
1 Crit Rev Oncol Hematol
1 Cureus
2 Diagn Cytopathol
1 Front Cell Infect Microbiol
4 Front Immunol
1 Front Med (Lausanne)
5 Front Oncol
1 Front Public Health
2 Gynecol Oncol
1 Health Expect
1 Hisp Health Care Int
1 Hum Vaccin Immunother
1 Int J Cancer
1 Int J Gynecol Cancer
1 Int J Radiat Biol
1 Int J Surg Pathol
2 iScience
1 Isr Med Assoc J
1 J Bioenerg Biomembr
1 J Cancer Res Clin Oncol
1 J Clin Invest
2 J Gynecol Obstet Hum Reprod
1 J Gynecol Oncol
1 J Low Genit Tract Dis
1 J Obstet Gynaecol Res
1 J Prim Care Community Health
1 J Radiat Res
1 Lancet Digit Health
1 Mol Genet Genomics
1 Prev Med Rep
1 Radiol Phys Technol
1 Res Health Serv Reg
1 Res Sq
1 Rev Assoc Med Bras (1992)
4 Sci Rep
1 Strahlenther Onkol
1 Transl Oncol
1 Trop Med Int Health
1 Womens Health (Lond)
1 Womens Health Rep (New Rochelle)
1 World J Surg Oncol
1 Zhonghua Bing Li Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. ZHANG T, Fan W, Liu K, Xu H, et al
    Time-dependent diffusion MRI for assessing tumor microstructure and prognostic risk factors in cervical cancer.
    Abdom Radiol (NY). 2026 Aug 8. doi: 10.1007/s00261-026-05703.
    PubMed         Abstract available

  2. MA X, Li Y, Yi S, Chen X, et al
    Time-dependent diffusion MRI for differentiating cervical cancer subtypes: impact of ROI delineation strategies on diagnostic performance.
    Abdom Radiol (NY). 2026 Aug 6. doi: 10.1007/s00261-026-05721.
    PubMed         Abstract available


    Acta Cytol

  3. KAYA FM, Ersoz S, Comba C, Demir O, et al
    Comparison of Cytological and/or Histopathological Results of Patients with Single and Multiple HPV Positivity.
    Acta Cytol. 2026;70:393-402.
    PubMed         Abstract available


    Acta Med Port

  4. SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
    Invasive Cervical Cancer Detection After Transition to Primary Human Papillomavirus Screening: Population-Based Linkage Study in Portugal.
    Acta Med Port. 2026;39:438-447.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  5. AARNIO R, Ahuja V, Ryen L, Bergengren L, et al
    Balancing diagnostic accuracy and cost in the follow-up of histological low-grade squamous intraepithelial lesions.
    Acta Obstet Gynecol Scand. 2026;105:1871-1878.
    PubMed         Abstract available


    Acta Oncol

  6. QIN H, Yang N, Wang Q, Tian L, et al
    Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.
    Acta Oncol. 2026;65:689-701.
    PubMed         Abstract available


    AJOG Glob Rep

  7. KEBEDE FB, Mare KU, Arage FG, Tiyou A, et al
    Predicting lifetime cervical cancer screening among sexually active women in low- and middle-income countries using machine learning models: evidence from Demographic and Health Surveys.
    AJOG Glob Rep. 2026;6:100669.
    PubMed         Abstract available

  8. MAEDA M, Kitai M, Akada M, Shimizu Y, et al
    Preoperative prediction of the need for postoperative adjuvant therapy in stage IB cervical cancer using tumor size measured on magnetic resonance imaging and serum squamous cell carcinoma antigen levels.
    AJOG Glob Rep. 2026;6:100671.
    PubMed         Abstract available


    Am J Case Rep

  9. FUKUNAGA C, Hiranuma K, Hirayama T, Yoshida E, et al
    Right Ventricular Metastasis From Cervical Cancer Treated With Pembrolizumab-Containing Chemotherapy: A Case Report and Literature Review.
    Am J Case Rep. 2026;27:e952931.
    PubMed         Abstract available


    Ann Ib Postgrad Med

  10. OLUMODEJI AM, Adefemi AK, Adedeji MO, Edun OQ, et al
    RADICAL HYSTERECTOMY FOR EARLY-STAGE CERVICAL CANCER IN A LOWRESOURCE SETTING: SURGICAL OUTCOMES AND LESSONS FROM A RETROSPECTIVE CROSS-SECTIONAL STUDY.
    Ann Ib Postgrad Med. 2026;24:39-45.
    PubMed         Abstract available


    BMJ Open

  11. TEBEJE TM, Metkie KA, Asgedom YS, Gebrekidan AY, et al
    Magnitude of human papillomavirus vaccination uptake and its determinants among adolescent girls in Lesotho: a cross-sectional study.
    BMJ Open. 2026;16:e110615.
    PubMed         Abstract available

  12. LYNN T, Sychareun V, Chaleunvong K, Vongxay V, et al
    Integrated service delivery to improve adolescent health and human papillomavirus (HPV) vaccination in Lao PDR: a quasi-experimental mixed-methods study - study protocol.
    BMJ Open. 2026;16:e098836.
    PubMed         Abstract available


    Cancer Cytopathol

  13. TANAKA S, Yamamoto Y, Yokota K, Yamamoto T, et al
    Diagnostic performance of artificial intelligence models trained on scattered single-cell images is not preserved for hyperchromatic crowded cell groups in cervical cytology.
    Cancer Cytopathol. 2026;134:e70140.
    PubMed         Abstract available


    Cancer Epidemiol

  14. JALINK M, King WD, Booth CM, Gien LT, et al
    The diagnosis to surgery interval and overall survival in patients with cervical cancer.
    Cancer Epidemiol. 2026;104:103190.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  15. LI N, Hu Y, van der Zee AGJ, Schuuring E, et al
    PAX1 and ZNF582 Methylation as a Triage Strategy in Cytologic and hrHPV+ Scrapings in Both Chinese and Dutch Cohorts.
    Cancer Epidemiol Biomarkers Prev. 2026;35:1411-1420.
    PubMed         Abstract available


    Cancer Rep (Hoboken)

  16. ADAM J, Mukuku O, Maseb'a Mwang Sulu S, Nsambi JB, et al
    Factors Associated With Cervical Cancer Awareness Among Women of Reproductive Age in the Democratic Republic of the Congo: Evidence From a Nationwide DHS Analysis.
    Cancer Rep (Hoboken). 2026;9:e70633.
    PubMed         Abstract available


    Cell Rep Med

  17. LOU H, Zhou Y, Li D, Zhang H, et al
    Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
    Cell Rep Med. 2026 Aug 4:102944. doi: 10.1016/j.xcrm.2026.102944.
    PubMed         Abstract available


    Clin Exp Vaccine Res

  18. JAISWAL A, Goyal P, Kumari S, Aggarwal D, et al
    Cervical cancer awareness and vaccine hesitancy with respect to HPV vaccination in urban community of Faridabad, Haryana, India.
    Clin Exp Vaccine Res. 2026;15:209-215.
    PubMed         Abstract available


    Clin J Oncol Nurs

  19. WATSON JL
    The Cancer That Could Disappear.
    Clin J Oncol Nurs. 2026;30:252-253.
    PubMed         Abstract available


    Clin Med Insights Oncol

  20. SUVVARI TK
    Turning the Tide on Cervical Cancer in India.
    Clin Med Insights Oncol. 2026;20:11795549261471277.
    PubMed        


    Clin Nucl Med

  21. CHENG J, Yuan H, Su M
    Pleural Metastasis as the Only Presentation of Recurrent Cervical Carcinoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006545.
    PubMed         Abstract available


    Clin Oncol (R Coll Radiol)

  22. XIAO Y, Yang L, Yu X, Cheng HJ, et al
    Efficacy and Safety of Camrelizumab Combined with Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Phase II Single-Arm Clinical Trial.
    Clin Oncol (R Coll Radiol). 2026;57:104293.
    PubMed         Abstract available


    Comput Struct Biotechnol J

  23. PROMTHONG C, Navakanitworakul R, Obaun K, Hanprasertpong J, et al
    Association between Urinary-Extracellular-Vesicle-Enriched Proteome Dynamics and Oncological Outcomes Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer.
    Comput Struct Biotechnol J. 2026;35:0196.
    PubMed         Abstract available


    Crit Rev Oncol Hematol

  24. AFTABSAVAD S, Arashkia A, Shokrgozar MA, Rahimi AA, et al
    mRNA vaccines targeting HPV E6/E7: A new frontier in cervical cancer immunotherapy.
    Crit Rev Oncol Hematol. 2026;226:105520.
    PubMed         Abstract available


    Cureus

  25. SOLIMAN S, Thomas T, Barker V, Aboujaoude M, et al
    Association of Increased MIEN1 Copy Number With Worse Outcomes in Lung Adenocarcinoma and Cervical Cancer.
    Cureus. 2026;18:e111880.
    PubMed         Abstract available


    Diagn Cytopathol

  26. YILDIZ BE, Koc N
    Cytomorphologic Findings Associated With High-Risk HPV Categories in PAP Smears.
    Diagn Cytopathol. 2026;54:637-643.
    PubMed         Abstract available

  27. KONG Y, Cao T, Pan Q, Zhao D, et al
    Basaloid Squamous Cell Carcinoma of the Uterine Cervix: An Often Aggressive Subtype Frequently Underestimated by Cytology.
    Diagn Cytopathol. 2026 May 14. doi: 10.1002/dc.70145.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  28. LI Z, Duan Z, Liu R, Yu S, et al
    Morphology-defined bacterial vaginosis and HPV-related cervical screening abnormalities: a two-year real-world study with histopathologic correlation.
    Front Cell Infect Microbiol. 2026;16:1890650.
    PubMed         Abstract available


    Front Immunol

  29. WEI L, Menghui H, Dandan Z, Xin W, et al
    HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products.
    Front Immunol. 2026;17:1892919.
    PubMed         Abstract available

  30. HUANG H, Liu L, Cui Y, Zhou F, et al
    Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming.
    Front Immunol. 2026;17:1848357.
    PubMed         Abstract available

  31. CHEN Y, Wang L, Li S, Huang J, et al
    Cross-scale modeling reveals a TFRC-driven immunosuppressive macrophage niche in cervical cancer.
    Front Immunol. 2026;17:1872944.
    PubMed         Abstract available

  32. ZHANG J, Chen C, Song H, Li D, et al
    NTMT1 (METTL11A) promotes MYC-dependent proliferation and downstream HLA-A suppression in cervical cancer.
    Front Immunol. 2026;17:1853434.
    PubMed         Abstract available


    Front Med (Lausanne)

  33. GUO Q, Xu C, Li J, Qi C, et al
    COVID-19 vaccination rates as a proxy for health system resilience: implications of development disparities for cervical cancer control during the pandemic.
    Front Med (Lausanne). 2026;13:1858206.
    PubMed         Abstract available


    Front Oncol

  34. BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
    Correction: Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes.
    Front Oncol. 2026;16:1929623.
    PubMed         Abstract available

  35. WANG X, Na J, Wang Y, Han B, et al
    Initial clinical experience with total Mullerian compartment resection for locally advanced cervical cancer: a single-center preliminary retrospective cohort study and learning-curve analysis.
    Front Oncol. 2026;16:1865445.
    PubMed         Abstract available

  36. VERGALASOVA I, Jiang C, Song T, Lombe D, et al
    Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration.
    Front Oncol. 2026;16:1872192.
    PubMed        

  37. QIU L, Li Y, Wang Y, Xie Y, et al
    Higher pre-treatment lymphocyte-to-monocyte ratio predicts better tumor shrinkage after external beam radiotherapy in locally advanced cervical cancer.
    Front Oncol. 2026;16:1917302.
    PubMed         Abstract available

  38. HOU H, Zhang L, Li C, Liu M, et al
    Plasma HPV ctDNA as a dynamic biomarker for treatment response and prognosis in locally advanced cervical cancer: protocol for a prospective cohort study.
    Front Oncol. 2026;16:1844938.
    PubMed         Abstract available


    Front Public Health

  39. BEJARANO-HERNANDEZ L, Chan A, Gosalia M, Moore M, et al
    Expanding HPV prevention across the life course: evidence on vaccine effectiveness in adults.
    Front Public Health. 2026;14:1894760.
    PubMed         Abstract available


    Gynecol Oncol

  40. FENG P, Shi K, Zhao W, Zhang J, et al
    Diagnostic value of FAM19A4/SOX1/PAX1 methylation in non-16/18 high-risk HPV cervical lesions.
    Gynecol Oncol. 2026;211:37-45.
    PubMed         Abstract available

  41. JIANG A, Chen Y, Ma F, Zhang H, et al
    Malignant transformation risk and management dilemmas of atypical lobular endocervical glandular hyperplasia: A retrospective cohort study comparing Peutz-Jeghers syndrome versus sporadic cases.
    Gynecol Oncol. 2026;211:51-58.
    PubMed         Abstract available


    Health Expect

  42. RENZAHO AMN, Challam S, Hartcher N, Smith M, et al
    Co-Designing Culturally Tailored Bowel, Cervical and Breast Cancer Screening Interventions With Migrant Communities: Towards Closing the Migration-Related Cancer-Equity Gap in New South Wales, Australia.
    Health Expect. 2026;29:e70805.
    PubMed         Abstract available


    Hisp Health Care Int

  43. DE CAMPOS MR, Carvalho LHSB, Campos AJR, Cora GR, et al
    Knowledge and Perception of Human Papillomavirus in Quilombola Communities in Northeast Brazil.
    Hisp Health Care Int. 2026;24:172-180.
    PubMed         Abstract available


    Hum Vaccin Immunother

  44. JINDAL R, R R, Ghanghas N, Gupta R, et al
    Addressing HPV vaccine hesitancy and misinformation in India through public health communication strategies.
    Hum Vaccin Immunother. 2026;22:2711551.
    PubMed         Abstract available


    Int J Cancer

  45. ARMAROLI P, Zappa M, Giorgi Rossi P, Carozzi FM, et al
    Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening.
    Int J Cancer. 2026 May 5. doi: 10.1002/ijc.70536.
    PubMed         Abstract available


    Int J Gynecol Cancer

  46. EL HAJJ H, Gouy S, Limkin E, Scherier S, et al
    Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm?
    Int J Gynecol Cancer. 2026 Jul 15:104874. doi: 10.1016/j.ijgc.2026.104874.
    PubMed        


    Int J Radiat Biol

  47. FENG X, He L, Gao Y, Qiu Y, et al
    Efficacy and safety of a combination of monoclonal antibodies and chemoradiotherapy for the treatment of locally advanced cervical cancer in Chinese patients: a systematic review and meta-analysis.
    Int J Radiat Biol. 2026 Aug 7:1-16. doi: 10.1080/09553002.2026.2710755.
    PubMed         Abstract available


    Int J Surg Pathol

  48. GUONA Z, Yabin S, Qian D, Yang L, et al
    Mixed Large Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Cervix: A Rare Entity.
    Int J Surg Pathol. 2026;34:1616-1622.
    PubMed         Abstract available


    iScience

  49. ZHU G, Piao Z, Gao Y, Cong X, et al
    Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1alpha-SIX1 axis.
    iScience. 2026;29:117007.
    PubMed         Abstract available

  50. CAMPANHA NOVAES LA, Oliveira RD, Tegami IL, Santiago Goncalves MF, et al
    Brazilian biorepository to support genome-wide association studies of colorectal, breast, and cervical cancer.
    iScience. 2026;29:116758.
    PubMed         Abstract available


    Isr Med Assoc J

  51. RAHAL ADAWI N, Ben Shachar I
    Ethnic Disparity in Cervical Cancer Stage at Diagnosis at a Tertiary Medical Center in Northern Israel: A Retrospective Study.
    Isr Med Assoc J. 2026;28:433-437.
    PubMed         Abstract available


    J Bioenerg Biomembr

  52. KUL KOPRULU T, Erkal Cam B
    Aloe vera extract disrupts mitochondrial bioenergetics and suppresses HeLa cervical cancer cell proliferation: Transcriptomic and metabolic insights into cisplatin co-treatment.
    J Bioenerg Biomembr. 2026;58:45.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  53. SCHLEICHER OM, Dietl AK, Behrens AS, Brueckner L, et al
    Regression of high-grade squamous intraepithelial lesions in women aged 30 years or younger: a retrospective cohort study.
    J Cancer Res Clin Oncol. 2026;152:152.
    PubMed         Abstract available


    J Clin Invest

  54. LIU SQ, Cheng XX, He S, Xia T, et al
    Corrigendum to Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis.
    J Clin Invest. 2026;136:e209744.
    PubMed        


    J Gynecol Obstet Hum Reprod

  55. MARCADET J, Ayadi S, Mal PA
    When pelvic actinomycosis mimics cervical neoplasia: A diagnostic challenge.
    J Gynecol Obstet Hum Reprod. 2026;55:103222.
    PubMed         Abstract available

  56. BADIGLIAN-FILHO L, Burnett A, Matak L, Ali O, et al
    vNOTES sentinel nodes removal from a remaining cervix.
    J Gynecol Obstet Hum Reprod. 2026;55:103189.
    PubMed         Abstract available


    J Gynecol Oncol

  57. LI X, Pan S, Qu P, Wu D, et al
    Burden and temporal trends of cervical cancer in reproductive-age females from 1990 to 2021 and projections to 2035 in G20 countries: a systematic analysis of the Global Burden of Disease Study 2021.
    J Gynecol Oncol. 2026 Jul 31. doi: 10.3802/jgo.2027.
    PubMed         Abstract available


    J Low Genit Tract Dis

  58. YOON HY, Jeon HS, Kim MJ, Kim JM, et al
    Comparison of Colorimetric LAMP and PCR for High-risk HPV Detection: Implications for Cervical Cancer Screening.
    J Low Genit Tract Dis. 2026 Aug 7. doi: 10.1097/LGT.0000000000000976.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  59. HSIAO KY, Lin HL, Chen CC
    Diagnostic Performance of HPV Testing Using Self-Collected Urine and Vaginal Samples for Detecting Cervical Precancer or Worse: A Meta-Analysis.
    J Obstet Gynaecol Res. 2026;52:e70434.
    PubMed         Abstract available


    J Prim Care Community Health

  60. LIU L, Du X, Zhao Y, Chen H, et al
    Cost-Related Barriers, Mental Distress, and Cervical Cancer Screening Adherence: A BRFSS 2024 Analysis.
    J Prim Care Community Health. 2026;17:21501319261475712.
    PubMed         Abstract available


    J Radiat Res

  61. KISHIMOTO Y, Sasaki M, Otsuka H, Kubo A, et al
    Utility of 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in assessing treatment response after chemoradiotherapy for cervical cancer.
    J Radiat Res. 2026 Aug 6:rrag060. doi: 10.1093.
    PubMed         Abstract available


    Lancet Digit Health

  62. AWAN UA, Zafar N, Khan S
    Infodemic preparedness and the 90-70-90 cervical cancer targets.
    Lancet Digit Health. 2026 Aug 5:101079. doi: 10.1016/j.landig.2026.101079.
    PubMed        


    Mol Genet Genomics

  63. HUANG C, Zhang W, Ma X, Li X, et al
    Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling.
    Mol Genet Genomics. 2026;301:165.
    PubMed         Abstract available


    Prev Med Rep

  64. ARYANPOUR M, Abolghasemi J, Moghadam SMK
    Psychosocial predictors of cervical cancer screening intention among female teachers in Karaj, Iran: An integrated behavioral model.
    Prev Med Rep. 2026;69:103589.
    PubMed         Abstract available


    Radiol Phys Technol

  65. LI BY, Fan T, Chen JY, Zhang YH, et al
    Internal feasibility evaluation of SAM-Med3D for cervical cancer clinical target volume segmentation on planning computed tomography.
    Radiol Phys Technol. 2026 Aug 7. doi: 10.1007/s12194-026-01092.
    PubMed         Abstract available


    Res Health Serv Reg

  66. BINTABARA D, Kamata CC, Mohamedi R, Konje E, et al
    Regional variations and predictors of low uptake of cervical cancer screening among women aged 30-49 years in Tanzania: a geospatial and multilevel analysis of population-based survey.
    Res Health Serv Reg. 2026;5:11.
    PubMed         Abstract available


    Res Sq

  67. GONZALEZ GMN, Msadabwe S, Njala B, Sakala D, et al
    Prior Cervical Cancer Screening, Social Determinants of Health, and HIV Status Among Patients at the Cancer Disease Hospital, Zambia.
    Res Sq [Preprint]. 2026 Jul 22:rs.3.rs-10345811.
    PubMed         Abstract available


    Rev Assoc Med Bras (1992)

  68. UCOK BS, Kinay T, Kusabbi IA, Dereli ML, et al
    The association of total oxidant status, total antioxidant status, and ischemia-modified albumin levels with cervical human papillomavirus infection and cervical intraepithelial neoplasia.
    Rev Assoc Med Bras (1992). 2026;72:e20252260.
    PubMed         Abstract available


    Sci Rep

  69. FAUZIA RP, Rahmani AA, Putri RA, Haryuni RD, et al
    Exploring the in-vitro evaluation of folic acid-modified gadolinium nanoparticles in HEK-293, HeLa, and KB cancer cells for targeted-MR-imaging agent candidate.
    Sci Rep. 2026;16:24462.
    PubMed         Abstract available

  70. DU M, Wei L, Geng M, Wang W, et al
    Cervical microbial dysbiosis in single HPV16-positive HSIL.
    Sci Rep. 2026;16:23893.
    PubMed         Abstract available

  71. ABUH SO, Barbora A, Nave V, Ben-Arie A, et al
    Attenuated total reflection Fourier transform infrared spectroscopy enables determination of the extent of precancer in cervical conization biopsy.
    Sci Rep. 2026;16:24132.
    PubMed         Abstract available

  72. SHAH K, Du C, Akgul A, Alshammari FS, et al
    Modelling the impact of awareness campaigns on HPV transmission dynamics: a neural network-enhanced mathematical model.
    Sci Rep. 2026;16:24277.
    PubMed         Abstract available


    Strahlenther Onkol

  73. YIGIT E, Gultekin M, Bayatfard P, Yuce Sari S, et al
    The impact of uterine position during brachytherapy on treatment outcomes and toxicity in patients with cervical cancer.
    Strahlenther Onkol. 2026 Aug 3. doi: 10.1007/s00066-026-02582.
    PubMed         Abstract available


    Transl Oncol

  74. MI J, Guo W, Li L, Wang S, et al
    Single-cell transcriptomics uncovers HPV-driven immune evasion and establishes a TAB2-based prognostic signature in cervical cancer.
    Transl Oncol. 2026;72:102935.
    PubMed         Abstract available


    Trop Med Int Health

  75. DOWOU RK, Salu S, Takyiwaa JA, Aboagye RG, et al
    Residency-Based Inequalities in Cervical Cancer Screening in Sub-Saharan Africa.
    Trop Med Int Health. 2026 Aug 2. doi: 10.1111/tmi.70152.
    PubMed         Abstract available


    Womens Health (Lond)

  76. ACQUAH-HAGAN G, Boateng D, Boakye K, Idan JS, et al
    Family and sexual functioning among women diagnosed with cervical cancer in Urban Ghana: A mixed-methods study.
    Womens Health (Lond). 2026;22:17455057261476899.
    PubMed         Abstract available


    Womens Health Rep (New Rochelle)

  77. CHEBAT A, Pharoun J, Rachid M, Bazzi M, et al
    Prevalence and Determinants of Knowledge and Attitudes Toward Cervical Cancer Prevention, Pap Smear Uptake, and Human Papilloma Virus Vaccination Among Lebanese Women.
    Womens Health Rep (New Rochelle). 2026;7:26884844261437618.
    PubMed         Abstract available


    World J Surg Oncol

  78. BHAT S, Devi V, Kabekkodu SP
    In silico analysis of driver genes in squamous cell carcinoma of the cervix: insights into their biological functions, prognosis, immune infiltration, and therapy.
    World J Surg Oncol. 2026;24:324.
    PubMed         Abstract available


    Zhonghua Bing Li Xue Za Zhi

  79. DONG F, Chen D, Shang JF, Fang W, et al
    [Diagnostic efficacy and teaching value of artificial intelligence-assisted diagnostic systems in cervical liquid-based cytology screening].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:744-751.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum